Clinical Trials on Cancer Patients Receiving Chemotherapy or Chemoradiotherapy in Italy
Total 10 results
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio...Consorzio Mario Negri SudWithdrawnPredictable BTP at Swallowing in in Head/Neck Cancer Patients Undergoing Radiotherapy Already Receiving Opioid Therapy for Background PainItaly
-
Italian Sarcoma GroupCompletedMetastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive | Standard ChemotherapyItaly
-
Catholic University of the Sacred HeartUnknownAdvanced Ovarian Cancer (Stage III or IV) After Neoadjuvant ChemotherapyItaly
-
Philogen S.p.A.TerminatedPancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical ResectionItaly, Germany
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRecruitingPatients With Suspected Ovarian Carcinoma | Non Oncological Patients or With EndometriosisItaly
-
AstraZenecaISTITUTO REGINA ELENA - CENTRO RICERCHE SPERIMENTALITerminatedPatients With Advanced Ovarian Cancer Sensitive to Platinum-based ChemotherapyItaly, Germany
-
Vall d'Hebron Institute of OncologyEuropean Organisation for Research and Treatment of Cancer - EORTCTerminatedChemotherapy | ColoRectal Cancer | MSI | Resistance, APCBelgium, Netherlands, Spain, Italy
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain